FSA
CME icon

Fort Sheridan Advisors’s CME Group CME Stock Holding History

Fort Sheridan Advisors’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32M Buy
108,202
+32
+0% +$9.51K 3.86% 5
2025
Q4 		$29.5M Hold
108,170
– – 3.75% 6
2025
Q3 		$29.2M Hold
108,170
– – 3.82% 4
2025
Q2 		$29.8M Hold
108,170
– – 4.25% 4
2025
Q1 		$28.7M Hold
108,170
– – 4.36% 4
2024
Q4 		$25.1M Hold
108,170
– – 3.67% 5
2024
Q3 		$23.9M Buy
108,170
+41
+0% +$8.48K 3.62% 4
2024
Q2 		$21.3M Hold
108,129
– – 3.44% 4
2024
Q1 		$23.3M Sell
108,129
-78,495
-42% -$16.5M 4.39% 4
2023
Q4 		$39.3M Buy
186,624
+275
+0.1% +$58.7K 7.84% 3
2023
Q3 		$37.3M Hold
186,349
– – 8.46% 3
2023
Q2 		$34.5M Hold
186,349
– – 7.88% 3
2023
Q1 		$35.7M Buy
186,349
+225
+0.1% +$40.7K 9.06% 3
2022
Q4 		$31.3M Hold
186,124
– – 10.18% 1
2022
Q3 		$33M Hold
186,124
– – 11.11% 1
2022
Q2 		$38.1M Hold
186,124
– – 12.39% 1
2022
Q1 		$44.3M Sell
186,124
-4,285
-2% -$1.01M 12.99% 1
2021
Q4 		$43.5M Buy
190,409
+10,611
+6% +$2.33M 12.55% 1
2021
Q3 		$34.8M Sell
179,798
-4,741
-3% -$961K 11.38% 1
2021
Q2 		$39.2M Buy
184,539
+116
+0.1% +$24.5K 13.09% 1
2021
Q1 		$37.7M Sell
184,423
-2,675
-1% -$527K 14.95% 1
2020
Q4 		$34.1M Hold
187,098
– – 16.61% 1
2020
Q3 		$31.3M Buy
187,098
+1,000
+0.5% +$168K 18.54% 1
2020
Q2 		$30.2M Sell
186,098
-234
-0.1% -$41.9K 18.59% 1
2020
Q1 		$32.2M Sell
186,332
-22,805
-11% -$4.54M 23.74% 1
2019
Q4 		$42M Sell
209,137
-4,489
-2% -$921K 22.51% 1
2019
Q3 		$45.1M Sell
213,626
-14,236
-6% -$2.97M 25.28% 1
2019
Q2 		$44.2M Sell
227,862
-655
-0.3% -$121K 25.59% 1
2019
Q1 		$37.6M Sell
228,517
-2,000
-0.9% -$354K 24.62% 1
2018
Q4 		$43.4M Buy
+230,517
New +$42.6M 30.73% 1

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fort Sheridan Advisors's CME Position: Q1 2026 in Review

Fort Sheridan Advisors increased its CME Group (CME) stake by 0.03% in Q1 2026, buying an estimated $9.51K and bringing the position to 108,202 shares worth $32M. The position accounts for 3.86% of the portfolio, ranked #5.

Fort Sheridan Advisors first reported a position in CME in Q4 2018 and has held it in 30 quarters since. The position peaked at $45.1M in Q3 2019. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Fort Sheridan Advisors held 108,202 shares of CME Group worth $32M as of Q1 2026.
  • Fort Sheridan Advisors bought 32 CME Group shares in Q1 2026, an estimated $9.51K.
  • CME Group made up 3.86% of Fort Sheridan Advisors's portfolio in Q1 2026, its #5 holding.
  • Fort Sheridan Advisors first reported a position in CME Group in Q4 2018 and has held it in 30 quarters since.
  • Fort Sheridan Advisors's CME Group position peaked at $45.1M in Q3 2019.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Fort Sheridan Advisors's 13F filing for Q1 2026, filed 6 May 2026.